Article,

Lipopolysaccharides directly increase calcium oscillations and intracellular calcium in human cardiomyocytes

, , , and .
Shock, (2014)
DOI: 10.1097/SHK.0000000000000184

Abstract

Lipopolysaccharides (LPS) are involved in endotoxin-mediated heart failure and chronic cardiac myopathies. We have shown previously that lipopolysaccharides (LPS) directly affect murine-derived HL-1 cardiac myocyte function via TLR-4 by inhibiting Ca2+ oscillations, by decreasing intracellular Ca2+ concentration, Ca2+i, and by impairing pacemaker Bfunny current, If, (Wondergem et al. Am. J. Physiol. Cell Physiol. 299:C665-71, 2010). Here we report LPS effects on human, induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (iCellA Cardiomyocytes). In marked contrast to the inhibitory effects of LPS on HL-1 cells, LPS (S. enteriditis or E. coli) in a dose-dependent manner (0.01- 1.0 2g/ml) increased the rate of Ca2+ oscillations and the Ca2+i in iCell Cardiomyocytes. Ca2+-free external solution abolished this stimulation by LPS. Ultra-pure LPS (E. coli), which is considered a TLR-4 specific agonist, exerted identical effects as the impure LPS. Prior addition of the monoclonalantibody blocking peptide, MAb hTLR4, attenuated the effect of ultra-pure LPS. Pam3Csk, a TLR-2 agonist, had no effect on Ca2+ oscillations or Ca2+i. iCell Cardiomyocytes also expressed TLR-4 as determined by flow cytometry. We conclude that LPS, acutely applied to human iCell Cardiomyocytes, results in TLR-4-dependent increases in Ca2+ oscillations and Ca2+i, which are consistent with a hyperdynamic response. This is in marked contrast to the hypodynamic response that we reported previously for acute effects of LPS on murine cardiomyocytes.

Tags

Users

  • @fcdi

Comments and Reviews